Filter
1137
Filtered Results: 1137
Text search:
antibodies
Featured
Recommendations
149
New Publications
286
Language
Document type
No document type
565
Guidelines
239
Studies & Reports
140
Manuals
60
Fact sheets
56
Strategic & Response Plan
27
Training Material
20
Situation Updates
10
Brochures
6
Resource Platforms
5
Infographics
4
Videos
4
App
1
Countries / Regions
India
93
Global
53
Nigeria
23
Nepal
22
Latin America and the Carribbean
21
South Africa
20
Tanzania
18
Philippines
16
Africa
15
Indonesia
14
Kenya
13
Middle East and North Africa
13
Western and Central Europe
13
Germany
12
Russia
12
Ethiopia
12
Liberia
12
Syria
11
Brazil
11
Sierra Leone
10
Malawi
10
West and Central Africa
10
East and Southern Africa
10
Uganda
10
Rwanda
9
Zambia
9
Congo, Democratic Republic of
7
Eastern Europe
7
Myanmar / Burma
7
Venezuela
6
Bangladesh
6
Namibia
6
Colombia
5
Ukraine
5
Yemen
5
Burkina Faso
4
Afghanistan
4
Peru
4
Guinea
4
South–East Asia Region
4
Pakistan
4
Lesotho
3
Turkey
3
Cameroon
3
Zimbabwe
3
Mozambique
3
USA
3
Cambodia
3
Asia
3
Saudi Arabia
3
Spain
3
Lebanon
3
Mali
3
South Sudan
3
Ecuador
3
Mexico
2
Ghana
2
Senegal
2
Niger
2
Qatar
2
Haiti
2
Jordan
2
Eastern Europe and Central Asia
2
Paraguay
2
North America
2
France
2
United Kingdom
2
Côte d’Ivoire / Ivory Coast
2
Bolivia
2
Argentina
2
Vietnam
2
Egypt
2
Sudan
2
Georgia
2
Chad
2
Libya
2
Botswana
2
Iraq
2
Somalia
2
Madagascar
2
Eswatini/ Swaziland
2
North Macedonia
1
Tajikistan
1
El Salvador
1
Serbia
1
Benin
1
Togo
1
China
1
Kazakhstan
1
Chile
1
Iran
1
Congo-Brazzaville
1
Uzbekistan
1
Morocco
1
Mauritania
1
Armenia
1
Dominican Republic
1
Western Pacific Region
1
Jamaica
1
Tunisia
1
Portugal
1
Belarus
1
Israel
1
Southern Africa
1
Papua New Guinea
1
Nicaragua
1
Moldova
1
Sri Lanka
1
Djibouti
1
Palestine
1
Poland
1
Honduras
1
Angola
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
369
Clinical Guidelines
176
Public Health
48
Women & Child Health
44
Pharmacy & Technologies
41
Capacity Building
26
Key Resources
16
Toolboxes
COVID-19
215
HIV
119
NTDs
88
Rapid Response
70
Ebola
47
TB
35
Zika
35
Refugee
23
Mental Health
21
Pharmacy
20
NCDs
20
Caregiver
16
Planetary Health
13
Polio
13
AMR
12
Cholera
6
Natural Hazards
4
Conflict
4
Health Financing Toolbox
3
Specific Hazards
2
Disability
2
Global Health Education
2
12 May 2021. This third survey in the series shows that the COVID-19 pandemic continues to impact societies, not only in terms of health, but also social and economic conditions and day-to-day life
Many African countries were amongst the most rapid to respond to the emerging threat of COVID-19, implementing large-scale interventions at very early stages of their epidemic. As demonstrated in this document using very simple models, this rapid mobilization and timeliness of implementing control m...
WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention
recommended
2nd edition, July 2021. This WHO and HRP guideline is designed to help countries make faster progress, more equitably, on the screening and treatment of cervical cancer. It includes some important shifts in WHO’s recommended approaches to cervical screening, and includes a total of 23 recommendati...
6 July 2021. The “WHO consolidated guidelines on tuberculosis. Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection 2021 update” is the latest document replacing the one issued in 2020. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included in the...
13 July 2021
The module provides an overview of factors to consider when monitoring the safety of COVID-19 vaccines administered to pregnant and breastfeeding women. It describes how national routine AEFI surveillance should be adapted to cater for this specific group of population using both pass...
Soil-transmitted helminths are a group of intestinal worms that include Ascaris lumbricoides (giant roundworm), Trichuris trichiura (whipworm), and Ancylostoma spp. (A. duodenale, A. ceylanicum) and Necator americanus (hookworms). Despite the clear biological differences among the different species,...
Has the world worked together to tackle the coronavirus? July 2021. This research paper assesses how the global community has responded to calls for greater solidarity in tackling the COVID-19 pandemic, and presents the insights of key stakeholders and experts in global health governance, health sec...
Este documento de referência foi preparado pelo Grupo de Trabalho sobre Vacinas contra COVID-19 do Grupo Consultivo Estratégico de Especialistas em Imunização (SAGE) para orientar as discussões do SAGE em sua reunião extraordinária de 8 de fevereiro de 2021, que resultou na publicação do do...
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an ...
Health ministries currently lack effective tools for monitoring and evaluation of schistosomiasis control programmes. Egg detection can be used, but the cost, challenges of obtaining samples, and the need for trained personnel and equipment limit the frequency of monitoring. The purpose of this TPP ...
The Nigeria Centre for Disease Control (NCDC) declared a Yellow Fever (YF) outbreak and activated a multi-sectoral Emergency Operations Centre for coordination of Yellow Fever response on 12 November 2020. The outbreak, which mainly affected three states of Delta, Enugu and Bauchi, already recorded ...
Временное руководство (Первый выпуск 24 мая 2021 г., Обновлено 21 октября 2021 г., Обновлено 15 марта 2022 г.
La leishmaniasis es un problema creciente de salud pública en el contextomundial. En Colombia, la situación es de alarma debido al incremento de casos de leishmaniasis cutánea que se viene registrando desde 2003 y el cambio en el patrón epidemiológico dado por la aparición de nuevos focos, el ...
Orientations provisoires 19 juillet 2021
La presente publicación describe la evidencia científica disponible sobre la utilidad del uso complementario de pruebas moleculares y de detección de anticuerpos para mejorar el diagnóstico de sospechosos de COVID-19. La utilización complementaria de ambas pruebas podría mejorar la identificac...
